Company / Income Tax
Incyte Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$377.8M
FY2025
5-year range
-$378.1M / $377.8M
FY2021-FY2025
Trend
+33.0%
vs FY2024
Sector context
#12 of 204
Health Care
What the data says
Among 204 Health Care companies, Incyte is in the bottom 6% for income tax. Income Tax has increased for 4 consecutive years, from -$378M in FY2021 to $378M in FY2025.
Based on SEC 10-K filings.
$378M in FY2025 with a 5-year CAGR of +130.1%. Top quartile in the Health Care sector.
Increased from $237M to $378M over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +26.1%
- 5-Year CAGR
- +130.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 204This company $377.8M Sector average $118.7M
▼
+218.2% above sector average
Key checks
Key Insights
- Incyte's income tax has grown for 4 consecutive years.
- 5-year CAGR of +130.1%, indicating consistent growth.
- In FY2025, income tax increased 33.0% year-over-year.
- Ranks #12 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.7%
- Strong return on equity: 25.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $377.8M | +33.0% |
| FY2024 | $284.0M | +20.0% |
| FY2023 | $236.6M | +25.6% |
| FY2022 | $188.5M | +149.8% |
| FY2021 | -$378.1M | -6559.5% |
| FY2020 | $5.9M | +587.1% |
| FY2019 | $852.0K | -85.4% |
| FY2018 | $5.9M | +587.1% |
| FY2017 | $852.0K | -73.2% |
| FY2016 | $3.2M | +210.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026